138 related articles for article (PubMed ID: 29920713)
1. Carboxylesterase and UDP-glucuronosyltransferases mediated metabolism of irinotecan: In vitro and in vivo insights from quantitative ultra-performance liquid chromatography-mass spectrometry analysis.
Qin Y; Kang A; Zhou G; Wang H; Wei W; Cao Y; Chen Y; Wang J; Shi Y; Tang Y; Jiang J
Biomed Chromatogr; 2018 Oct; 32(10):e4320. PubMed ID: 29920713
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of an UPLC-MS/MS method for the quantification of irinotecan, SN-38 and SN-38 glucuronide in plasma, urine, feces, liver and kidney: Application to a pharmacokinetic study of irinotecan in rats.
Basu S; Zeng M; Yin T; Gao S; Hu M
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Mar; 1015-1016():34-41. PubMed ID: 26894853
[TBL] [Abstract][Full Text] [Related]
3. High-performance liquid chromatographic assay for glucuronidation activity of 7-ethyl-10-hydroxycamptothecin (SN-38), the active metabolite of irinotecan (CPT-11), in human liver microsomes.
Hanioka N; Jinno H; Nishimura T; Ando M; Ozawa S; Sawada J
Biomed Chromatogr; 2001 Aug; 15(5):328-33. PubMed ID: 11507714
[TBL] [Abstract][Full Text] [Related]
4. A validated UPLC-MS/MS method to determine free and total irinotecan and its two metabolites in human plasma after intravenous administration of irinotecan hydrochloride liposome injection.
Zhuang Q; Liu X; Sun Z; Wang H; Jiang J
J Pharm Biomed Anal; 2019 Jun; 170():112-123. PubMed ID: 30921645
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a high-performance liquid chromatography-tandem mass spectrometry method for the simultaneous determination of irinotecan and its main metabolites in human plasma and its application in a clinical pharmacokinetic study.
Marangon E; Posocco B; Mazzega E; Toffoli G
PLoS One; 2015; 10(2):e0118194. PubMed ID: 25689738
[TBL] [Abstract][Full Text] [Related]
6. Determination of irinotecan and its metabolite SN-38 in rabbit plasma and tumors using a validated method of tandem mass spectrometry coupled with liquid chromatography.
Park DJ; Won JH; Cho AR; Yun HJ; Heo JH; Hwhang TH; Lee DH; Kim WM
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jul; 962():147-152. PubMed ID: 24927278
[TBL] [Abstract][Full Text] [Related]
7. A new UPLC-MS/MS method for the determination of irinotecan and 7-ethyl-10-hydroxycamptothecin (SN-38) in mice: application to plasma and brain pharmacokinetics.
Goldwirt L; Lemaitre F; Zahr N; Farinotti R; Fernandez C
J Pharm Biomed Anal; 2012 Jul; 66():325-33. PubMed ID: 22551773
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of an UPLC-MS/MS method for the determination of irinotecan (CPT-11), SN-38 and SN-38 glucuronide in human plasma and peritoneal tumor tissue from patients with peritoneal carcinomatosis.
Gasthuys E; van Ovost J; Vande Casteele S; Cosyns S; Ceelen W; Van Bocxlaer J; Vermeulen A
J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Feb; 1233():123980. PubMed ID: 38215697
[TBL] [Abstract][Full Text] [Related]
9. Study the pharmacokinetics of AV-45 in rat plasma and metabolism in liver microsomes by ultra-performance liquid chromatography with mass spectrometry.
Yin W; Zhou X; Qiao J; Zhu L
Biomed Chromatogr; 2012 May; 26(5):666-71. PubMed ID: 21932381
[TBL] [Abstract][Full Text] [Related]
10. Determination of irinotecan, SN-38 and SN-38 glucuronide using HPLC/MS/MS: Application in a clinical pharmacokinetic and personalized medicine in colorectal cancer patients.
Atasilp C; Chansriwong P; Sirachainan E; Reungwetwattana T; Puangpetch A; Prommas S; Sirilerttrakul S; Rerkarmnuaychoke B; Wongwaisayawan S; Sukasem C
J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28393405
[TBL] [Abstract][Full Text] [Related]
11. High-performance liquid chromatographic method for the simultaneous determination of the camptothecin derivative irinotecan hydrochloride, CPT-11, and its metabolites SN-38 and SN-38 glucuronide in rat plasma with a fully automated on-line solid-phase extraction system, PROSPEKT.
Kurita A; Kaneda N
J Chromatogr B Biomed Sci Appl; 1999 Mar; 724(2):335-44. PubMed ID: 10219676
[TBL] [Abstract][Full Text] [Related]
12. Genetic predisposition to the metabolism of irinotecan (CPT-11). Role of uridine diphosphate glucuronosyltransferase isoform 1A1 in the glucuronidation of its active metabolite (SN-38) in human liver microsomes.
Iyer L; King CD; Whitington PF; Green MD; Roy SK; Tephly TR; Coffman BL; Ratain MJ
J Clin Invest; 1998 Feb; 101(4):847-54. PubMed ID: 9466980
[TBL] [Abstract][Full Text] [Related]
13. Determination of geniposide in adjuvant arthritis rat plasma by ultra-high performance liquid chromatography tandem mass spectrometry method and its application to oral bioavailability and plasma protein binding ability studies.
Chen J; Wu H; Xu GB; Dai MM; Hu SL; Sun LL; Wang W; Wang R; Li SP; Li GQ
J Pharm Biomed Anal; 2015 Apr; 108():122-8. PubMed ID: 25771205
[TBL] [Abstract][Full Text] [Related]
14. Impact of obesity on accumulation of the toxic irinotecan metabolite, SN-38, in mice.
Mallick P; Shah P; Gandhi A; Ghose R
Life Sci; 2015 Oct; 139():132-8. PubMed ID: 26334566
[TBL] [Abstract][Full Text] [Related]
15. Streptomycin alleviates irinotecan-induced delayed-onset diarrhea in rats by a mechanism other than inhibition of β-glucuronidase activity in intestinal lumen.
Kurita A; Kado S; Matsumoto T; Asakawa N; Kaneda N; Kato I; Uchida K; Onoue M; Yokokura T
Cancer Chemother Pharmacol; 2011 Jan; 67(1):201-13. PubMed ID: 20354702
[TBL] [Abstract][Full Text] [Related]
16. Determination of drug interactions occurring with the metabolic pathways of irinotecan.
Charasson V; Haaz MC; Robert J
Drug Metab Dispos; 2002 Jun; 30(6):731-3. PubMed ID: 12019202
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of an ultra-high performance LC-MS/MS assay for intracellular SN-38 in human solid tumour cell lines: comparison with a validated HPLC-fluorescence method.
Ghazaly E; Perry J; Kitromilidou C; Powles T; Joel S
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Oct; 969():213-8. PubMed ID: 25195021
[TBL] [Abstract][Full Text] [Related]
18. A rapid, simple and reliable HPLC-triple quadrupole tandem mass spectrometer method for a simultaneous quantification of irinotecan and its active metabolite 7-ethyl-10-hydroxycamptothecin (SN38) in mouse plasma.
Ahn G; Park DM; Park JW; Kim HY; Cho JY; Rhee SJ; Jang IJ; Kim HK
Biomed Chromatogr; 2014 Jul; 28(7):919-22. PubMed ID: 24458571
[TBL] [Abstract][Full Text] [Related]
19. Shengjiang Xiexin Decoction Alters Pharmacokinetics of Irinotecan by Regulating Metabolic Enzymes and Transporters: A Multi-Target Therapy for Alleviating the Gastrointestinal Toxicity.
Guan HY; Li PF; Wang XM; Yue JJ; He Y; Luo XM; Su MF; Liao SG; Shi Y
Front Pharmacol; 2017; 8():769. PubMed ID: 29163158
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of a sensitive UHPLC-MS/MS method for quantitative analysis of farrerol in rat plasma: Application to pharmacokinetic and bioavailability studies.
Piao L; Zang M; Gu Y; Liu B
Biomed Chromatogr; 2017 Nov; 31(11):. PubMed ID: 28493423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
